{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T17:00:00Z","timestamp":1778173200860,"version":"3.51.4"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T00:00:00Z","timestamp":1695600000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801537"],"award-info":[{"award-number":["81801537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801537"],"award-info":[{"award-number":["81801537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801537"],"award-info":[{"award-number":["81801537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801537"],"award-info":[{"award-number":["81801537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81801537"],"award-info":[{"award-number":["81801537"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"the National Key Research and Developmental Program of China","award":["Grant No. 2021YFC2700404"],"award-info":[{"award-number":["Grant No. 2021YFC2700404"]}]},{"name":"the National Key Research and Developmental Program of China","award":["Grant No. 2021YFC2700404"],"award-info":[{"award-number":["Grant No. 2021YFC2700404"]}]},{"name":"the National Key Research and Developmental Program of China","award":["Grant No. 2021YFC2700404"],"award-info":[{"award-number":["Grant No. 2021YFC2700404"]}]},{"name":"the National Key Research and Developmental Program of China","award":["Grant No. 2021YFC2700404"],"award-info":[{"award-number":["Grant No. 2021YFC2700404"]}]},{"name":"the National Key Research and Developmental Program of China","award":["Grant No. 2021YFC2700404"],"award-info":[{"award-number":["Grant No. 2021YFC2700404"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Whether pretreatment with gonadotropin-releasing hormone agonist (GnRHa) can improve the pregnancy outcomes in frozen-thawed embryo transfer (FET) cycles is controversial. The inconsistencies in the results of different studies would be related to the characteristics of the included patients and the protocol of GnRHa use. In this study, we investigated the efficacy of pretreatment with a long-acting GnRH agonist in the early follicular phase of FET cycles and determined which population was suitable for the protocol.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We retrospectively included 630 and 1141 patients in the GnRHa FET and hormone replacement treatment (HRT) FET without GnRHa groups respectively, between October 2017 and March 2019 at a university-affiliated in vitro fertilization center. On the second or third day of menstruation, 3.75\u00a0mg of leuprorelin was administered. After 14\u00a0days, HRT was initiated for endometrial preparation. No significant differences were observed between the two groups in terms of patient characteristics. However, the GnRHa FET group showed a higher percentage of endometrium with a triple line pattern (94.8% vs 89.6%, p\u2009&lt;\u20090.001) on the day of progesterone administration, with increased implantation (35.6% vs 29.8%, <jats:italic>p<\/jats:italic>\u2009=\u20090.005), clinical pregnancy (49.8% vs 43.3%, <jats:italic>p<\/jats:italic>\u2009=\u20090.008), and live birth rate (39.4% vs 33.7%, <jats:italic>p<\/jats:italic>\u2009=\u20090.016), than the HRT FET cycles with similar endometrial thickness, ectopic pregnancy and early miscarriage rates. Binary logistic regression analysis showed the GnRHa FET group to be associated with an increased chance of clinical pregnancy (<jats:italic>P<\/jats:italic>=0.028, odds ratio [OR] 1.32, 95% confidence interval [CI] 1.03\u20131.70) and live birth (<jats:italic>P<\/jats:italic>=0.013, odds ratio [OR] 1.34, 95% confidence interval [CI] 1.06\u20131.70) compared to the HRT FET without GnRHa group. After subgroup analysis, we found that the GnRHa FET group showed a significantly higher live birth rate in the subgroups of age\u2009&lt;\u200940\u00a0years, primary infertility, with polycystic ovary syndrome (PCOS), and irregular menstruation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Pretreatment with a long-acting GnRHa during the early follicular phase improved the live birth rate in FET cycles. Age\u2009&lt;\u200940\u00a0years, primary infertility, PCOS, and irregular menstruation are effective indications for endometrial preparation with GnRHa pretreatment in FET cycles. However, further randomized controlled trials are required to verify these results.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-023-01277-0","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T03:10:47Z","timestamp":1695611447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pretreatment with a long-acting GnRH agonist for frozen-thawed embryo transfer cycles: how to improve live birth?"],"prefix":"10.1186","volume":"16","author":[{"given":"Bin","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaojuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nenghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,25]]},"reference":[{"issue":"5","key":"1277_CR1","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1093\/humupd\/dmt030","volume":"19","author":"ER Groenewoud","year":"2013","unstructured":"Groenewoud ER, Cantineau AE, Kollen BJ, Macklon NS, Cohlen BJ. What is the optimal means of preparing the endometrium in frozen-thawed embryo transfer cycles? A systematic review and meta-analysis. Hum Reprod Update. 2013;19(5):458\u201370.","journal-title":"Hum Reprod Update"},{"key":"1277_CR2","first-page":"CD003414","volume":"7","author":"T Ghobara","year":"2017","unstructured":"Ghobara T, Gelbaya TA, Ayeleke RO. Cycle regimens for frozen-thawed embryo transfer. Cochrane Database Syst Rev. 2017;7:CD003414.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"1277_CR3","first-page":"233","volume":"31","author":"MS Kupka","year":"2016","unstructured":"European IVFMC, European Society of Human R, Embryology, Kupka MS, D\u2019Hooghe T, Ferraretti AP, et al. Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHRE. Hum Reprod. 2016;31(2):233\u201348.","journal-title":"Hum Reprod."},{"issue":"4","key":"1277_CR4","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1093\/humrep\/deh183","volume":"19","author":"T El-Toukhy","year":"2004","unstructured":"El-Toukhy T, Taylor A, Khalaf Y, Al-Darazi K, Rowell P, Seed P, et al. Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomised study. Hum Reprod. 2004;19(4):874\u20139.","journal-title":"Hum Reprod"},{"issue":"1","key":"1277_CR5","first-page":"1","volume":"9","author":"E Azimi Nekoo","year":"2015","unstructured":"Azimi Nekoo E, Chamani M, Shahrokh Tehrani E, Hossein Rashidi B, Davari Tanha F, Kalantari V. Artificial Endometrial Preparation for Frozen-Thawed Embryo Transfer with or without Pretreatment with Depot gonadotropin Releasing Hormone Agonist in Women with Regular Menses. J Fam Reprod Health. 2015;9(1):1\u20134.","journal-title":"J Fam Reprod Health"},{"issue":"9","key":"1277_CR6","doi-asserted-by":"publisher","first-page":"587","DOI":"10.29252\/ijrm.16.9.587","volume":"16","author":"A Samsami","year":"2018","unstructured":"Samsami A, Chitsazi Z, Namazi G. Frozen thawed embryo transfer cycles; A comparison of pregnancy outcomes with and without prior pituitary suppression by GnRH agonists: An RCT. Int J Reprod Biomed. 2018;16(9):587\u201394.","journal-title":"Int J Reprod Biomed"},{"issue":"5","key":"1277_CR7","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/S0015-0282(02)02960-6","volume":"77","author":"L Dal Prato","year":"2002","unstructured":"Dal Prato L, Borini A, Cattoli M, Bonu MA, Sciajno R, Flamigni C. Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist. Fertil Steril. 2002;77(5):956\u201360.","journal-title":"Fertil Steril"},{"issue":"4","key":"1277_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.5468\/ogs.2018.61.4.489","volume":"61","author":"J Kang","year":"2018","unstructured":"Kang J, Park J, Chung D, Lee SH, Park EY, Han KH, et al. Comparison of the clinical outcome of frozen-thawed embryo transfer with and without pretreatment with a gonadotropin-releasing hormone agonist. Obstet Gynecol Sci. 2018;61(4):489\u201396.","journal-title":"Obstet Gynecol Sci"},{"issue":"1O","key":"1277_CR9","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1093\/humrep\/13.10.2712","volume":"13","author":"A Simon","year":"1998","unstructured":"Simon A, Hurwitz A, Zentner BS, Bdolah Y, Laufer N. Transfer of frozen-thawed embryos in artificially prepared cycles with and without prior gonadotrophin-releasing hormone agonist suppression: a prospective randomized study. Hum Reprod. 1998;13(1O):2712\u20137.","journal-title":"Hum Reprod"},{"issue":"2","key":"1277_CR10","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s13224-016-0936-5","volume":"67","author":"SA Hebisha","year":"2017","unstructured":"Hebisha SA, Adel HM. GnRh agonist treatment improves implantation and pregnancy rates of frozen-thawed embryos transfer. J Obstet Gynaecol India. 2017;67(2):133\u20136.","journal-title":"J Obstet Gynaecol India"},{"issue":"4","key":"1277_CR11","first-page":"191","volume":"12","author":"S Movahedi","year":"2018","unstructured":"Movahedi S, Aleyasin A, Agahosseini M, Safdarian L, Abroshan S, Khodaverdi S, et al. Endometrial preparation for women undergoing embryo transfer frozen-thawed embryo transfer with and without pretreatment with gonadotropin releasing hormone agonists. J Fam Reprod Health. 2018;12(4):191\u20136.","journal-title":"J Fam Reprod Health"},{"issue":"5","key":"1277_CR12","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1016\/j.rbmo.2014.08.005","volume":"29","author":"A van de Vijver","year":"2014","unstructured":"van de Vijver A, Polyzos NP, Van Landuyt L, De Vos M, Camus M, Stoop D, et al. Cryopreserved embryo transfer in an artificial cycle: is GnRH agonist down-regulation necessary? Reprod Biomed Online. 2014;29(5):588\u201394.","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"1277_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/1471-0528.16461","volume":"128","author":"L Luo","year":"2021","unstructured":"Luo L, Chen M, Wen Y, Zhang L, Zhou C, Wang Q. Pregnancy outcome and cost-effectiveness comparisons of artificial cycle-prepared frozen embryo transfer with or without GnRH agonist pretreatment for polycystic ovary syndrome: a randomised controlled trial. BJOG. 2021;128(4):667\u201374.","journal-title":"BJOG"},{"issue":"12","key":"1277_CR14","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/oxfordjournals.humrep.a137983","volume":"8","author":"T al-Shawaf","year":"1993","unstructured":"al-Shawaf T, Yang D, al-Magid Y, Seaton A, Iketubosin F, Craft I. Ultrasonic monitoring during replacement of frozen\/thawed embryos in natural and hormone replacement cycles. Hum Reprod. 1993;8(12):2068\u201374.","journal-title":"Hum Reprod"},{"issue":"3","key":"1277_CR15","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0015-0282(16)56943-X","volume":"62","author":"JT Queenan Jr","year":"1994","unstructured":"Queenan JT Jr, Veeck LL, Seltman HJ, Muasher SJ. Transfer of cryopreserved-thawed pre-embryos in a natural cycle or a programmed cycle with exogenous hormonal replacement yields similar pregnancy results. Fertil Steril. 1994;62(3):545\u201350.","journal-title":"Fertil Steril"},{"issue":"4","key":"1277_CR16","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1159\/000292274","volume":"41","author":"V Tanos","year":"1996","unstructured":"Tanos V, Friedler S, Zajicek G, Neiger M, Lewin A, Schenker JG. The impact of endometrial preparation on implantation following cryopreserved-thawed-embryo transfer. Gynecol Obstet Invest. 1996;41(4):227\u201331.","journal-title":"Gynecol Obstet Invest"},{"issue":"3","key":"1277_CR17","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.fertnstert.2005.09.015","volume":"85","author":"TA Gelbaya","year":"2006","unstructured":"Gelbaya TA, Nardo LG, Hunter HR, Fitzgerald CT, Horne G, Pease EE, et al. Cryopreserved-thawed embryo transfer in natural or down-regulated hormonally controlled cycles: a retrospective study. Fertil Steril. 2006;85(3):603\u20139.","journal-title":"Fertil Steril"},{"issue":"4","key":"1277_CR18","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.fertnstert.2015.07.1131","volume":"104","author":"G Mounce","year":"2015","unstructured":"Mounce G, McVeigh E, Turner K, Child TJ. Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization. Fertil Steril. 2015;104(4):915\u201320 e1.","journal-title":"Fertil Steril"},{"issue":"2","key":"1277_CR19","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.fertnstert.2008.11.027","volume":"93","author":"MJ Hill","year":"2010","unstructured":"Hill MJ, Miller KA, Frattarelli JL. A GnRH agonist and exogenous hormone stimulation protocol has a higher live-birth rate than a natural endogenous hormone protocol for frozen-thawed blastocyst-stage embryo transfer cycles: an analysis of 1391 cycles. Fertil Steril. 2010;93(2):416\u201322.","journal-title":"Fertil Steril"},{"key":"1277_CR20","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ejogrb.2017.04.010","volume":"213","author":"QV Le","year":"2017","unstructured":"Le QV, Abhari S, Abuzeid OM, DeAnna J, Satti MA, Abozaid T, et al. Modified natural cycle for embryo transfer using frozen-thawed blastocysts: a satisfactory option. Eur J Obstet Gynecol Reprod Biol. 2017;213:58\u201363.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"6","key":"1277_CR21","doi-asserted-by":"publisher","first-page":"300060520918474","DOI":"10.1177\/0300060520918474","volume":"48","author":"Q Qi","year":"2020","unstructured":"Qi Q, Luo J, Wang Y, Xie Q. Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes. J Int Med Res. 2020;48(6):300060520918474.","journal-title":"J Int Med Res"},{"issue":"4","key":"1277_CR22","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1007\/s11596-018-1923-0","volume":"38","author":"D Xie","year":"2018","unstructured":"Xie D, Chen F, Xie SZ, Chen ZL, Tuo P, Zhou R, et al. Artificial cycle with or without a depot gonadotropin-releasing hormone agonist for frozen-thawed embryo transfer: an assessment of infertility type that is most suitable. Current medical science. 2018;38(4):626\u201331.","journal-title":"Current medical science"},{"key":"1277_CR23","doi-asserted-by":"publisher","first-page":"722253","DOI":"10.3389\/fendo.2021.722253","volume":"12","author":"J Xu","year":"2021","unstructured":"Xu J, Li SZ, Yin MN, Liang PL, Li P, Sun L. Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with GnRH agonist: a randomized controlled trial at two centers. Front Endocrinol (Lausanne). 2021;12:722253.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1277_CR24","first-page":"319","volume":"18","author":"R Davar","year":"2020","unstructured":"Davar R, Dashti S, Omidi M. Endometrial preparation using gonadotropin-releasing hormone agonist prior to frozen-thawed embryo transfer in women with repeated implantation failure: an RCT. Int J Reprod Biomed. 2020;18(5):319\u201326.","journal-title":"Int J Reprod Biomed"},{"issue":"14","key":"1277_CR25","doi-asserted-by":"publisher","first-page":"7517","DOI":"10.3390\/ijms23147517","volume":"23","author":"AS Lagana","year":"2022","unstructured":"Lagana AS, Uccella S, Chiantera V, Garzon S. Molecular biology of human fertility: stepping towards a Tailored approach. Int J Mol Sci. 2022;23(14):7517.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"1277_CR26","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00404-017-4633-0","volume":"297","author":"V Salamun","year":"2018","unstructured":"Salamun V, Verdenik I, Lagana AS, Vrtacnik-Bokal E. Should we consider integrated approach for endometriosis-associated infertility as gold standard management? Rationale and results from a large cohort analysis. Arch Gynecol Obstet. 2018;297(3):613\u201321.","journal-title":"Arch Gynecol Obstet"},{"issue":"18","key":"1277_CR27","doi-asserted-by":"publisher","first-page":"15902","DOI":"10.3390\/ijms231810902","volume":"23","author":"M Mikus","year":"2022","unstructured":"Mikus M, Goldstajn MS, Brlecic I, Dumancic S, Lagana AS, Chiantera V, et al. CTLA4-linked autoimmunity in the pathogenesis of endometriosis and related infertility: a systematic review. Int J Mol Sci. 2022;23(18):15902.","journal-title":"Int J Mol Sci"},{"issue":"6","key":"1277_CR28","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1093\/humupd\/dmr029","volume":"17","author":"D Kyrou","year":"2011","unstructured":"Kyrou D, Kolibianakis EM, Fatemi HM, Tarlatzi TB, Devroey P, Tarlatzis BC. Increased live birth rates with GnRH agonist addition for luteal support in ICSI\/IVF cycles: a systematic review and meta-analysis. Hum Reprod Update. 2011;17(6):734\u201340.","journal-title":"Hum Reprod Update"},{"issue":"10","key":"1277_CR29","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1093\/humrep\/del215","volume":"21","author":"HC Ruan","year":"2006","unstructured":"Ruan HC, Zhu XM, Luo Q, Liu AX, Qian YL, Zhou CY, et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod. 2006;21(10):2521\u20139.","journal-title":"Hum Reprod"},{"issue":"5","key":"1277_CR30","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1507\/endocrj.40.539","volume":"40","author":"M Iwashita","year":"1993","unstructured":"Iwashita M, Kudo Y, Shinozaki Y, Takeda Y. Gonadotropin-releasing hormone increases serum human chorionic gonadotropin in pregnant women. Endocr J. 1993;40(5):539\u201344.","journal-title":"Endocr J"},{"issue":"3","key":"1277_CR31","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1093\/humupd\/dmv059","volume":"22","author":"R Maggi","year":"2016","unstructured":"Maggi R, Cariboni AM, Marelli MM, Moretti RM, Andre V, Marzagalli M, et al. GnRH and GnRH receptors in the pathophysiology of the human female reproductive system. Hum Reprod Update. 2016;22(3):358\u201381.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1277_CR32","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/molehr\/5.3.234","volume":"5","author":"EM Casan","year":"1999","unstructured":"Casan EM, Raga F, Polan ML. GnRH mRNA and protein expression in human preimplantation embryos. Mol Hum Reprod. 1999;5(3):234\u20139.","journal-title":"Mol Hum Reprod"},{"issue":"8","key":"1277_CR33","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1093\/humrep\/16.8.1671","volume":"16","author":"S Fujii","year":"2001","unstructured":"Fujii S, Sato S, Fukui A, Kimura H, Kasai G, Saito Y. Continuous administration of gonadotrophin-releasing hormone agonist during the luteal phase in IVF. Hum Reprod. 2001;16(8):1671\u20135.","journal-title":"Hum Reprod"},{"issue":"6","key":"1277_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1111\/j.1365-2265.1993.tb02138.x","volume":"38","author":"FJ Broekmans","year":"1993","unstructured":"Broekmans FJ, Bernardus RE, Broeders A, Berkhout G, Schoemaker J. Pituitary responsiveness after administration of a GnRH agonist depot formulation: Decapeptyl CR. Clin Endocrinol. 1993;38(6):579\u201387.","journal-title":"Clin Endocrinol"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-023-01277-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-023-01277-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,19]],"date-time":"2023-11-19T06:38:52Z","timestamp":1700375932000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-023-01277-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,25]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1277"],"URL":"https:\/\/doi.org\/10.1186\/s13048-023-01277-0","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,25]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of Reproductive Medicine Center, Xiangya Hospital, Central South University (No.20190815).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare that this research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"197"}}